Bodycote (BOY) Rating Reiterated by Numis Securities
Other equities research analysts also recently issued research reports about the stock. restated a hold rating and issued a GBX 900 ($12.21) price objective on shares of Bodycote in a research report on Friday, September 29th. Deutsche Bank restated a buy rating and issued a GBX 990 ($13.43) price objective on shares of Bodycote in a research report on Friday, October 13th. JPMorgan Chase & Co. restated a neutral rating and issued a GBX 850 ($11.53) price objective on shares of Bodycote in a research report on Friday, October 27th. Beaufort Securities restated a buy rating on shares of Bodycote in a research report on Friday, October 27th. Finally, Liberum Capital restated a buy rating and issued a GBX 1,025 ($13.90) price objective (up previously from GBX 910 ($12.34)) on shares of Bodycote in a research report on Thursday, October 26th. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The stock has an average rating of Buy and an average price target of GBX 957.27 ($12.98).
Shares of Bodycote (BOY) traded up GBX 9 ($0.12) during trading hours on Monday, reaching GBX 992 ($13.45). 273,132 shares of the company were exchanged, compared to its average volume of 296,255. The firm has a market capitalization of $1,890.00 and a P/E ratio of 2,419.51. Bodycote has a 1 year low of GBX 628 ($8.52) and a 1 year high of GBX 1,043 ($14.14).
Bodycote plc is a provider of thermal processing services. The Company has six operating segments, split between Aerospace, Defense and Energy (ADE) and Automotive and General Industrial (AGI) business areas: ADE-Western Europe; ADE-North America; ADE-Emerging markets; AGI-Western Europe; AGI-North America, and AGI-Emerging markets.
Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.